Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary Prevention

September 11, 2018

In this program, experts James Underberg, MD, MS (Chair), Alan Brown, MD, Peter Jones, MD, and Pamela Morris, MD present compelling presentations and cases focusing on the evidence with, and use of, non-statin therapies for LDL-C lowering in the settings of primary and secondary prevention.

CME 0.00 Credits